'Game-changer' GLP-1s could fix America's obesity crisis—but 2 inequalities stand in the way
Wells Fargo Industry Insights' Robin Wenzel says the drugs are rewriting healthcare economics, but the math doesn't "pencil out" too often.
Read the full story at fm-term-meta-233910339-mutual-fund | FORTUNE →